SARA KAPLAN: Open Payments
NPI 1295460723 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 43 payments from 8 companies in 2025. Trend: 2023 $610 · 2024 $1,441 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $728 |
| UCB, Inc. | 7 | $186 |
| Galderma Laboratories, L.P. | 5 | $184 |
| ABBVIE INC. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Organon LLC | 3 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $38 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, RINVOQ, Zoryve, TREMFYA, VTAMA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
